While NOD2 variants are known to impair bacterial clearance and disrupt NFκB activation (13, 29, 38, 39), paradoxically, the gut mucosa of IBD patients often shows heightened NFκB activity (40–44). This evidence concerns the gene NFKB1 and inflammatory bowel disease.